European Cardiology Review最新文献

Clinical Management of Non-alcoholic Steatohepatitis and the Role of the Cardiologist 非酒精性脂肪性肝炎的临床治疗与心脏病专家的作用

IF 3

European Cardiology Review Pub Date : 2023-12-22 DOI: 10.15420/ecr.2023.22

Carlos Millán-Rodríguez, Carlos Palacios Castelló Palacios Castelló, M. Caballero-Valderrama, Gonzalo Barón Esquivias

{"title":"Clinical Management of Non-alcoholic Steatohepatitis and the Role of the Cardiologist","authors":"Carlos Millán-Rodríguez, Carlos Palacios Castelló Palacios Castelló, M. Caballero-Valderrama, Gonzalo Barón Esquivias","doi":"10.15420/ecr.2023.22","DOIUrl":"https://doi.org/10.15420/ecr.2023.22","url":null,"abstract":"Non-alcoholic fatty liver disease (NAFLD) is a spectrum of fat-associated liver conditions that increase risk of cardiovascular disease and mortality. The diagnosis and clinical management of NAFLD remain a challenge for cardiologists. Our group performed a systematic review in PubMed of the relationship between NAFLD and cardiovascular disease, identifying 35 relevant articles. NAFLD is likely to be the liver’s expression of metabolic syndrome and increases the risk of several cardiovascular diseases, including coronary artery disease, stroke, heart failure and electrical disorders, and chronic kidney disease. Echocardiography is a useful tool to check early subclinical abnormalities in heart structure and function linked to NAFLD progression, such as cardiac diastolic impairment or epicardial fat thickness. Currently, NAFLD is predominantly managed by lifestyle changes with the aim of weight loss, based on the Mediterranean diet and intense exercise training. Despite the lack of approved drugs for NAFLD, new potential treatments, mainly glucagon-like peptide-1 agonists or sodium–glucose cotransporter 2 inhibitors, could change cardiologists’ approach to this pathology.","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":"9 4","pages":""},"PeriodicalIF":3.0,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138944741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Evidence-based Management of Left Main Coronary Artery Disease 左冠状动脉主干疾病的循证管理

IF 3

European Cardiology Review Pub Date : 2023-12-19 DOI: 10.15420/ecr.2023.36

G. Torres-Ruiz, Nuria Mallofré-Vila, P. Rojas-Flores, Pablo Carrión-Montaner, E. Bosch-Peligero, Daniel Valcárcel-Paz, Ada Cardiel-Perez, J. Guindo-Soldevila, Antonio Martínez-Rubio

{"title":"Evidence-based Management of Left Main Coronary Artery Disease","authors":"G. Torres-Ruiz, Nuria Mallofré-Vila, P. Rojas-Flores, Pablo Carrión-Montaner, E. Bosch-Peligero, Daniel Valcárcel-Paz, Ada Cardiel-Perez, J. Guindo-Soldevila, Antonio Martínez-Rubio","doi":"10.15420/ecr.2023.36","DOIUrl":"https://doi.org/10.15420/ecr.2023.36","url":null,"abstract":"Left main coronary artery disease (LMCAD) is associated with high morbidity and mortality due to the large myocardial mass at risk. Although medical treatment may be an option in selected low-risk patients, revascularisation is recommended to improve survival in the majority of patients presenting with a significant left main stenosis. In the past decade, multiple randomised clinical trials and meta-analyses have compared coronary artery bypass grafting surgery (CABG) versus percutaneous coronary intervention (PCI), finding controversial results. The strategy for LMCAD revascularisation is still challenging. Coronary anatomy complexity, clinical features and patient preferences are key elements to be considered by the heart team. The current guidelines define CABG as standard therapy, but the continuous improvements in PCI techniques, the use of intracoronary imaging and functional assessment make PCI a feasible alternative in selected patients, particularly in those with comorbidities and contraindications to CABG. This review analyses the most important studies comparing CABG versus PCI in patients with LMCAD.","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":" 4","pages":""},"PeriodicalIF":3.0,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138961117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Selection of Non-vitamin K Antagonist Oral Anticoagulant for Stroke Prevention in Atrial Fibrillation Based on Patient Profile: Perspectives from Vietnamese Experts. Part 2 根据患者情况选择非维生素 K 拮抗剂口服抗凝药预防心房颤动患者中风：越南专家的观点。第二部分

IF 3

European Cardiology Review Pub Date : 2023-12-15 DOI: 10.15420/ecr.2023.25

Minh That Ton, T. H. Q. Ho, Viet Lan Nguyen, Hung Manh Pham, S. Hoang, Nhan Thanh Vo, Thai Quoc Nguyen, Linh Tran Pham, Ton Duy Mai, Thang Huy Nguyen

{"title":"Selection of Non-vitamin K Antagonist Oral Anticoagulant for Stroke Prevention in Atrial Fibrillation Based on Patient Profile: Perspectives from Vietnamese Experts. Part 2","authors":"Minh That Ton, T. H. Q. Ho, Viet Lan Nguyen, Hung Manh Pham, S. Hoang, Nhan Thanh Vo, Thai Quoc Nguyen, Linh Tran Pham, Ton Duy Mai, Thang Huy Nguyen","doi":"10.15420/ecr.2023.25","DOIUrl":"https://doi.org/10.15420/ecr.2023.25","url":null,"abstract":"Part 1 of this review provided an overview of AF in Vietnam, with a particular focus on primary and secondary stroke prevention. Part 2 explores the management of AF in special, high-risk and clinically common patient populations including those with renal impairment, diabetes, the elderly, and those with coronary artery disease. Furthermore, Part 2 addresses the challenges posed by patients with AF who have a bioprosthetic valve, a group situated in a grey area of consideration. Managing AF in these patient groups presents unique clinical challenges that require careful consideration. Physicians are tasked with addressing specific clinical questions to identify the optimal anticoagulation strategy for each individual. To inform these decisions, subgroup analyses from pivotal studies are presented alongside real-world data derived from clinical practice. By synthesising available information and considering the nuanced clinical context, the aim is to provide informed perspectives that align with current medical knowledge and contribute to the enhancement of patient care in these challenging scenarios.","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":"97 1","pages":""},"PeriodicalIF":3.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138997611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Selection of Non-vitamin K Antagonist Oral Anticoagulant for Stroke Prevention in Atrial Fibrillation Based on Patient Profile: Perspectives from Vietnamese Experts. Part 1 根据患者情况选择非维生素 K 拮抗剂口服抗凝药预防心房颤动患者中风：越南专家的观点。第一部分

IF 3

European Cardiology Review Pub Date : 2023-12-15 DOI: 10.15420/ecr.2023.24

T. H. Q. Ho, Minh That Ton, Viet Lan Nguyen, Hung Manh Pham, S. Hoang, Nhan Thanh Vo, Thai Quoc Nguyen, Linh Tran Pham, Ton Duy Mai, Thang Huy Nguyen

{"title":"Selection of Non-vitamin K Antagonist Oral Anticoagulant for Stroke Prevention in Atrial Fibrillation Based on Patient Profile: Perspectives from Vietnamese Experts. Part 1","authors":"T. H. Q. Ho, Minh That Ton, Viet Lan Nguyen, Hung Manh Pham, S. Hoang, Nhan Thanh Vo, Thai Quoc Nguyen, Linh Tran Pham, Ton Duy Mai, Thang Huy Nguyen","doi":"10.15420/ecr.2023.24","DOIUrl":"https://doi.org/10.15420/ecr.2023.24","url":null,"abstract":"In Asia, especially Vietnam, AF is a common arrhythmia and is linked to a higher risk of stroke and systemic embolism. Anticoagulation therapy for stroke prevention in AF patients can result in bleeding complications. To effectively manage AF, adopting appropriate anticoagulation and addressing modifiable risk factors are crucial. Vietnamese clinicians are particularly interested in non-vitamin K antagonist oral anticoagulants (NOACs), a recent development in AF treatment. However, the lack of head-to-head trials comparing NOACs makes selecting a specific NOAC challenging. This review aims to provide a comprehensive overview of the available clinical evidence on NOACs for stroke prevention in AF to assist clinicians in making informed decisions and improving treatment outcomes in patients with AF. The first part of this review will present the current landscape of AF in Vietnam, focusing on AF prevalence and highlighting gaps in clinical practice. Furthermore, this part extensively discusses the anticoagulation strategy for both primary and secondary stroke prevention in AF.","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":"26 64","pages":""},"PeriodicalIF":3.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139000601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Evolution of Coronary Artery Spasm: How the Pendulum Has Swung 冠状动脉痉挛的演变:钟摆是如何摆动的

IF 3

European Cardiology Review Pub Date : 2023-09-01 DOI: 10.15420/ecr.2023.08

John F Beltrame, Peter Ong, Filippo Crea

引用次数: 1

Gaps in Modern Heart Failure and Chronic Kidney Disease Research. 现代心力衰竭和慢性肾脏疾病研究的空白。

IF 3

European Cardiology Review Pub Date : 2023-08-23 eCollection Date: 2023-01-01 DOI: 10.15420/ecr.2022.64

Simran Singh Parmar, Vasantha Muthuppalaniappan, Debasish Banerjee

引用次数: 0

Comment on 'Leadless Pacemakers: Current Achievements and Future Perspectives'. 评论 "无铅起搏器：当前成就与未来展望 "发表评论。

IF 3.2

European Cardiology Review Pub Date : 2023-08-18 eCollection Date: 2023-01-01 DOI: 10.15420/ecr.2022.58

Zaki Akhtar, Manav Sohal, Mark M Gallagher

引用次数: 0

The Utility of CT Coronary Angiography in Chronic Total Occlusion Percutaneous Coronary Intervention. CT冠状动脉造影在慢性完全闭塞经皮冠状动脉介入治疗中的应用。

IF 3

European Cardiology Review Pub Date : 2023-08-18 eCollection Date: 2023-01-01 DOI: 10.15420/ecr.2022.61

Firas Yassin, Jawad Khan, Abdul Mozid, Derek Connolly, Vinoda Sharma

{"title":"The Utility of CT Coronary Angiography in Chronic Total Occlusion Percutaneous Coronary Intervention.","authors":"Firas Yassin, Jawad Khan, Abdul Mozid, Derek Connolly, Vinoda Sharma","doi":"10.15420/ecr.2022.61","DOIUrl":"10.15420/ecr.2022.61","url":null,"abstract":"Chronic total occlusion (CTO) of the coronary arteries is a relatively common finding in routine coronary angiography. Of late, there has been considerable improvement in the success rate of percutaneous intervention for coronary CTO, attributed to technological advancement and skills development. CT coronary angiogram (CTCA) is a simple, non-invasive, and cost-effective test that aids in the diagnosis and management of coronary artery disease, including CTOs. The development of multi-slice CT and the use of 3D volume rendering images has revolutionised the diagnostic abilities of CTCA, with improvements in imaging quality and detailed anatomical and morphological characterisation of the plaque disease. In CTO percutaneous intervention, CTCA is used in pre-procedural planning, applying scoring systems to predict the likely success of the intervention as well as the post-procedural evaluation and follow-up. This review examines the different uses of CTCA in CTO intervention, its impact on successful recanalisation and the areas for future consideration.","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":"18 ","pages":"e48"},"PeriodicalIF":3.0,"publicationDate":"2023-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bc/8d/ecr-18-e48.PMC10466269.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10138078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Transvenous Lead Extraction: Work in Progress. 经静脉提取铅：正在进行中。

IF 3

European Cardiology Review Pub Date : 2023-06-19 eCollection Date: 2023-01-01 DOI: 10.15420/ecr.2023.06

Zaki Akhtar, Manav Sohal, Mary N Sheppard, Mark M Gallagher

引用次数: 2

Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum. 先兆子痫与心血管疾病：从妊娠到产后。

IF 3

European Cardiology Review Pub Date : 2023-06-07 eCollection Date: 2023-01-01 DOI: 10.15420/ecr.2022.56

Veronica Giorgione, Matthew Cauldwell, Basky Thilaganathan

{"title":"Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum.","authors":"Veronica Giorgione, Matthew Cauldwell, Basky Thilaganathan","doi":"10.15420/ecr.2022.56","DOIUrl":"10.15420/ecr.2022.56","url":null,"abstract":"Hypertensive disorders of pregnancy (HDP) complicate approximately 10% of pregnancies. In addition to multiorgan manifestations related to endothelial dysfunction, HDP confers an increased risk of cardiovascular disease during delivery hospitalisation, such as heart failure, pulmonary oedema, acute MI and cerebrovascular events. However, the cardiovascular legacy of HDP extends beyond birth since these women are significantly more likely to develop cardiovascular risk factors in the immediate postnatal period and major cardiovascular disease in the long term. The main mediator of cardiovascular disease in women with a history of HDP is chronic hypertension, followed by obesity, hypercholesterolaemia and diabetes. Therefore, optimising blood pressure levels from the immediate postpartum period until the first months postnatally could have beneficial effects on the development of hypertension and improve long-term cardiovascular health. Peripartum screening based on maternal demographic, and clinical and echocardiographic data could help clinicians identify women with HDP at highest risk of developing postpartum hypertension who would benefit from targeted primary cardiovascular prevention.","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":"18 ","pages":"e42"},"PeriodicalIF":3.0,"publicationDate":"2023-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b3/1c/ecr-18-e42.PMC10345941.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9880456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1